Predictive and prognostic factors of efficacy of third-line chemotherapy in patients with unresectable pancreatic cancer: a cohort-based study.
Evrard C, Pelras A, Rivet S, Bachet JB, Dubreuil O, Pointet AL, Taieb J, Lahlou W, Portal A, Lepère C, Lecomte T, Chautard R, Williet N, Phelip JM, Coutzac C, Soularue E, Marthey L, Abdallah R, Thirot Bidault A, Artru P, Desrame J, Le Roy B, Jary M, Hammel P, Trouilloud I, Lourenco N, Hautefeuille V, Dahan L, Pernot S, Béchade D, Pozet A, Bonnetain F, Locher C, Dréanic J, Coriat R, Tchoundjeu B, Foucher Y, Tougeron D.
Evrard C, et al. Among authors: trouilloud i.
Oncologist. 2025 Jun 4;30(6):oyaf125. doi: 10.1093/oncolo/oyaf125.
Oncologist. 2025.
PMID: 40515476
Free PMC article.